Betashares Global Healthcare Currency Hedged ETF
BetaShares · MarketGrader Developed World Healthcare Index · Since 2020
Annual fee
0.45%
$45/year per $10,000
Fund size
$158M
AUD
Dividend yield
4%
Semi-annually · approx. as at Q3 2026
Holdings
59
companies
Dividend yield is a trailing distribution figure. Past performance is not a reliable indicator of future returns.
Next estimated distribution: ~December 2026 (estimated, not guaranteed; confirm with the fund manager). Distribution calendar → · View full distribution history →
DRUG gives you concentrated exposure to global healthcare leaders, companies like Eli Lilly, UnitedHealth, Johnson & Johnson, AbbVie, and Novo Nordisk. Healthcare is one of the relatively defensive sectors, demand for medicines and medical services is less sensitive to economic cycles than consumer discretionary spending. At 0.45% the fee sits in the mid-range for a thematic ETF.
Based on publicly available fund data. Not a recommendation to buy or sell.
Strengths
Watch out for
| Company | Weight |
|---|---|
| Eli Lilly and Company | 9.3% |
| Johnson & Johnson | 8.0% |
| Abbvie Inc. | 6.0% |
| UnitedHealth Group Inc. | 5.6% |
| Roche Holding Ag | 5.1% |
| Astrazeneca Plc | 5.0% |
| Merck & Co., Inc. | 4.2% |
| Novartis Ag | 3.7% |
| Thermo Fisher Scientific Inc. | 3.0% |
| Amgen Inc. | 2.9% |
See how DRUG combines with your other ETFs: Stock X-Ray →
| Sector | Weight |
|---|---|
| Health Care | 99.2% |
| Consumer Staples | 0.7% |
| Country | Weight |
|---|---|
| United States | 79.6% |
| Switzerland | 6.4% |
| Britain | 3.2% |
| Japan | 2.9% |
| Denmark | 2.5% |
| China | 1.9% |
Historical returns
Past performance is not a reliable indicator of future returns.
Data as at Q3 2026. Past performance is not a reliable indicator of future returns. Figures are approximate total returns in AUD including distributions. Source: fund manager fact sheets.
Compare DRUG with similar ETFs
Side-by-side fees, holdings overlap and performance.
Find near-twins of DRUG →General information only, not financial advice. ETFLens does not hold an AFSL. Always read the relevant PDS and consider seeking advice from a licensed financial adviser.
DRUG gives you concentrated exposure to global healthcare leaders, companies like Eli Lilly, UnitedHealth, Johnson & Johnson, AbbVie, and Novo Nordisk.
DRUG's annual management fee is 0.45% p.a. ($45 per $10,000 invested).
DRUG pays distributions semi-annually. Distributions are not guaranteed and will vary.